BENEFIT Extension Study
NCT00544037
·
clinicaltrials.gov ↗
COMPLETED
Status
283
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Interferon beta-1b (Betaseron, BAY86-5046)
Sponsor
Bayer